- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
0 new
High return on equity, past performance and sound balance sheet.
2 companies
Consun Pharmaceutical Group
Market Cap: HK$9.4b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$11.16
7D
-4.1%
1Y
95.8%
Uni-Bio Science Group
Market Cap: HK$716.5m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.13
7D
56.3%
1Y
98.4%